Similarly, ApoB was identified as the prioritized risk factor for CAD in the primary (marginal inclusion probability, 0.92; P=0.005; Table 1) and replication (marginal inclusion probability, 0.80; P=0.004) analyses, in keeping with the previously established role of ApoB in CAD (Tables VII and VIII in the Data Supplement).15,16 These results provide strong, consistent support for the role of ApoB as the primary lipoprotein risk factor for PAD and CAD. Here, APOB is linked to peripheral arterial disease.